Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01595178 · ClinicalTrials.gov registry record · Early Phase 1
Combination SBIRT for Emergency Department Patients Who Drink and Smoke
A Early Phase 1 study of Smoking and Drinking, sponsored by Yale University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT01595178: Completed Early Phase 1 study of Smoking and Drinking, sponsored by Yale University.
NCT01595178 is a Early Phase 1 study of Smoking and Drinking that has completed, run by Yale University. The registered enrollment target is 50 participants, below the 455-participant average among 123 other Smoking trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01595178, a Early Phase 1 study of Smoking and Drinking, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Smoking and drinking are two of the three leading causes of preventable deaths in the United States today. Using both alcohol and tobacco significantly multiplies the risk of disease and death from myocardial infarction, COPD, and multiple cancers. Combined use of these substances is extremely common; people who drink are three times more likely than the general population to smoke, and tobacco dependent individuals are four times more likely than the general population to be alcohol-dependent. Research has shown that there is a high prevalence of unmet substance abuse treatment need among adult Emergency Department (ED) patients. The current project aims to conduct a pilot feasibility study with 50 adult ED patients to develop a brief counseling intervention that is feasible and acceptable to patients who are both smokers and at-risk drinkers to help them reduce these behaviors. The overarching aim of this line of research is to find the best treatment for ED patients who are combo smokers and at-risk drinkers. The study will focus on the development of an intervention that will be tested in a future larger scale randomized clinical trial.
Primary Outcome
Descriptive summary of patient reports of areas in need of help as reported during assessments
Interventions
- BEHAVIORAL Combined BNI
Study Locations (1)
Connecticut
- Yale New Haven Hospital Emergency Department - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-05-08 |
| Phase | Early Phase 1 |
What the finished NCT01595178 record still lists
NCT01595178 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 455-participant average among 123 other Smoking trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Smoking appearing as the primary indexed condition, and to 1 intervention - of which Combined BNI is the first listed.
NCT01595178 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT01595178 about?
NCT01595178 is a clinical study titled "Combination SBIRT for Emergency Department Patients Who Drink and Smoke". Smoking and drinking are two of the three leading causes of preventable deaths in the United States today. Using both alcohol and tobacco significantly multiplies the risk of disease and death from myocardial infarction, COPD, and multiple cancers. Combined use of these substances is extremely commo...
What is the current status of trial NCT01595178?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 50 participants. The study started on 2012-06. Estimated completion is 2014-05-08.
What conditions does trial NCT01595178 study?
This clinical trial studies the following conditions: Smoking, Drinking.
What interventions are being tested in trial NCT01595178?
The interventions under investigation include: Combined BNI (BEHAVIORAL).
Who is sponsoring clinical trial NCT01595178?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01595178 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01595178's enrollment target sits among peer trials
50 95th of 123 higher than 28 of 123 other Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer
ACTIVE NOT RECRUITING · Early Phase 1
-
Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)
ACTIVE NOT RECRUITING · Early Phase 1
-
Hollings Cancer Center Varenicline Sampling Study
COMPLETED · Early Phase 1
-
Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette Choices
COMPLETED · Early Phase 1
-
Integrating Financial Coaching and Smoking Cessation Coaching
RECRUITING · Phase 3
-
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia